SSA
CELU icon

Schonfeld Strategic Advisors’s Celularity CELU Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,000
Closed -$46K – 2632
2022
Q3 		$46K Buy
+2,000
New +$60.7K ﹤0.01% 2649
2021
Q2 		– Sell
-8,143
Closed -$821K – 1980
2021
Q1 		$821K Buy
+8,143
New +$835K 0.01% 970

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Schonfeld Strategic Advisors's CELU Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Celularity (CELU) in Q4 2022, closing a stake of 2,000 shares — an estimated $46K sold.

Schonfeld Strategic Advisors first reported a position in CELU in Q1 2021 and held it in 2 quarters. The position peaked at $821K in Q1 2021. 73 funds tracked by Wall St. Rank hold CELU as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Celularity position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 2,000 Celularity shares in Q4 2022, an estimated $46K.
  • Schonfeld Strategic Advisors first reported a position in Celularity in Q1 2021 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Celularity position peaked at $821K in Q1 2021.
  • 73 funds tracked by Wall St. Rank held Celularity as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.